Found: 172
Select item for more details and to access through your institution.
First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1495, doi. 10.1007/s10637-020-00924-3
- By:
- Publication type:
- Article
A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1–4, as a single dose and multiple doses in patients with solid malignancies.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 445, doi. 10.1007/s10637-019-00780-w
- By:
- Publication type:
- Article
First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 507, doi. 10.1007/s10637-018-0697-3
- By:
- Publication type:
- Article
Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1072, doi. 10.1007/s10637-018-0658-x
- By:
- Publication type:
- Article
A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1058, doi. 10.1007/s10637-015-0270-2
- By:
- Publication type:
- Article
Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics.
- Published in:
- 2014
- By:
- Publication type:
- Erratum
Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 1, p. 104, doi. 10.1007/s10637-013-9953-8
- By:
- Publication type:
- Article
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines).
- Published in:
- Hepatology Research, 2023, v. 53, n. 5, p. 383, doi. 10.1111/hepr.13892
- By:
- Publication type:
- Article
Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version).
- Published in:
- Hepatology Research, 2022, v. 52, n. 4, p. 329, doi. 10.1111/hepr.13746
- By:
- Publication type:
- Article
Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 2, p. 193, doi. 10.1159/000531820
- By:
- Publication type:
- Article
Regression of Tumor Thrombus in the Suprahepatic Vena Cava of Hepatocellular Carcinoma and Conversion Hepatectomy Induced by Lenvatinib.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 3, p. 278, doi. 10.1159/000520822
- By:
- Publication type:
- Article
Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 249, doi. 10.1159/000514420
- By:
- Publication type:
- Article
Pathological Complete Response in Conversion Hepatectomy Induced by Lenvatinib for Advanced Hepatocellular Carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Current Status of Hepatocellular Carcinoma Treatment in Japan.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, p. 37, doi. 10.2165/1163024-S0-000000000-00000
- By:
- Publication type:
- Article
Early Relapse of Unresectable Gallbladder Cancer after Discontinuation of Gemcitabine Monotherapy Administered for 5 Years in a Patient Who Had Complete Response to the Treatment.
- Published in:
- Case Reports in Oncology, 2013, v. 6, n. 3, p. 531, doi. 10.1159/000356080
- By:
- Publication type:
- Article
Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 1, p. 57, doi. 10.1001/jama.2014.7189
- By:
- Publication type:
- Article
Sorafenib for the treatment of unresectable hepatocellular carcinoma.
- Published in:
- Biologics: Targets & Therapy, 2008, v. 2, n. 4, p. 779
- By:
- Publication type:
- Article
The Prognostic Utility of a Geriatric Assessment for Patients with Pancreatic Cancer Receiving Gemcitabine-based Chemotherapy: A Prospective Observational Study.
- Published in:
- Internal Medicine, 2023, v. 62, n. 11, p. 1573, doi. 10.2169/internalmedicine.9689-22
- By:
- Publication type:
- Article
A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic Cancer.
- Published in:
- Internal Medicine, 2023, v. 62, n. 3, p. 327, doi. 10.2169/internalmedicine.9504-22
- By:
- Publication type:
- Article
FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10654-3
- By:
- Publication type:
- Article
Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study.
- Published in:
- Liver International, 2016, v. 36, n. 8, p. 1196, doi. 10.1111/liv.13096
- By:
- Publication type:
- Article
Response Evaluation Criteria in Cancer of the Liver version 5 (RECICL 2019 revised version).
- Published in:
- Hepatology Research, 2019, v. 49, n. 9, p. 981, doi. 10.1111/hepr.13394
- By:
- Publication type:
- Article
Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version).
- Published in:
- Hepatology Research, 2016, v. 46, n. 1, p. 3, doi. 10.1111/hepr.12542
- By:
- Publication type:
- Article
Multicenter cooperative case survey of hepatitis B virus reactivation by chemotherapeutic agents.
- Published in:
- Hepatology Research, 2015, v. 45, n. 12, p. 1220, doi. 10.1111/hepr.12496
- By:
- Publication type:
- Article
Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update.
- Published in:
- Hepatology Research, 2012, v. 42, n. 6, p. 523, doi. 10.1111/j.1872-034X.2012.00981.x
- By:
- Publication type:
- Article
Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version).
- Published in:
- 2010
- By:
- Publication type:
- Report
Factors Influencing Cancer Patients' Choice of End-of-Life Care Place.
- Published in:
- Journal of Palliative Medicine, 2018, v. 21, n. 6, p. 751, doi. 10.1089/jpm.2017.0481
- By:
- Publication type:
- Article
Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2021, v. 28, n. 1, p. 26, doi. 10.1002/jhbp.870
- By:
- Publication type:
- Article
Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2021, v. 28, n. 1, p. 1, doi. 10.1002/jhbp.868
- By:
- Publication type:
- Article
Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2018, v. 25, n. 5, p. 261, doi. 10.1002/jhbp.547
- By:
- Publication type:
- Article
Role of chemotherapy in treatments for biliary tract cancer.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2012, v. 19, n. 4, p. 337, doi. 10.1007/s00534-011-0494-2
- By:
- Publication type:
- Article
ASO Author Reflections: Characteristics of Surgery for Biliary Tract Cancer that Should be Considered During the Design of Future Clinical Trials.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 12, p. 7384, doi. 10.1245/s10434-023-13922-5
- By:
- Publication type:
- Article
A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 12, p. 7331, doi. 10.1245/s10434-023-13913-6
- By:
- Publication type:
- Article
Characteristics of patients with longer treatment period of lenvatinib for unresectable hepatocellular carcinoma: A post-hoc analysis of post-marketing surveillance study in Japan.
- Published in:
- PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0298420
- By:
- Publication type:
- Article
Clinical characteristics of Japanese patients with epithelioid hemangioendothelioma: a multicenter retrospective study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 39, doi. 10.1159/000318020
- By:
- Publication type:
- Article
An autopsy case study of lymphocytic hypophysitis induced by nivolumab treatment for esophageal malignant melanoma.
- Published in:
- Pathology International, 2021, v. 71, n. 12, p. 831, doi. 10.1111/pin.13161
- By:
- Publication type:
- Article
Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: a retrospective multicenter cohort study.
- Published in:
- BMC Cancer, 2020, v. 20, n. 1, p. N.PAG, doi. 10.1186/s12885-020-07462-4
- By:
- Publication type:
- Article
Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: a retrospective multicenter cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 456, doi. 10.1007/s10147-024-02467-6
- By:
- Publication type:
- Article
Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 2, p. 188, doi. 10.1007/s10147-023-02432-9
- By:
- Publication type:
- Article
Treatments for elderly cancer patients and reforms to social security systems in Japan.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 2, p. 310, doi. 10.1007/s10147-021-02099-0
- By:
- Publication type:
- Article
Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 5, p. 894, doi. 10.1007/s10147-018-1283-6
- By:
- Publication type:
- Article
Current status of chemoradiotherapy for locally advanced pancreatic cancer in Japan.
- Published in:
- International Journal of Clinical Oncology, 2008, v. 13, n. 2, p. 127, doi. 10.1007/s10147-007-0739-x
- By:
- Publication type:
- Article
APC:T1556fs and STK11 mutations in duodenal adenomas and adenocarcinomas.
- Published in:
- Surgery Today, 2018, v. 48, n. 8, p. 765, doi. 10.1007/s00595-018-1649-4
- By:
- Publication type:
- Article
Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine‐Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX‐BC Study).
- Published in:
- Oncologist, 2021, v. 26, n. 2, p. 97, doi. 10.1002/onco.13547
- By:
- Publication type:
- Article
High-Resolution Computed Tomography Findings for Patients With Drug-Induced Pulmonary Toxicity, With Special Reference to Hypersensitivity Pneumonitis-Like Patterns in Gemcitabine-Induced Cases.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
High-Resolution Computed Tomography Findings for Patients With Drug-Induced Pulmonary Toxicity, With Special Reference to Hypersensitivity Pneumonitis-Like Patterns in Gemcitabine-Induced Cases.
- Published in:
- Oncologist, 2013, v. 18, n. 4, p. 454, doi. 10.1634/theoncologist.2012-0248
- By:
- Publication type:
- Article
The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective.
- Published in:
- Oncologist, 2010, v. 15, p. 5, doi. 10.1634/theoncologist.2010-S4-05
- By:
- Publication type:
- Article